CA2468211A1 - .alpha. lipoic acid based food supplement for increasing lean muscle mass and strength - Google Patents
.alpha. lipoic acid based food supplement for increasing lean muscle mass and strength Download PDFInfo
- Publication number
- CA2468211A1 CA2468211A1 CA002468211A CA2468211A CA2468211A1 CA 2468211 A1 CA2468211 A1 CA 2468211A1 CA 002468211 A CA002468211 A CA 002468211A CA 2468211 A CA2468211 A CA 2468211A CA 2468211 A1 CA2468211 A1 CA 2468211A1
- Authority
- CA
- Canada
- Prior art keywords
- food supplement
- lipoic acid
- strength
- present
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 51
- 210000003205 muscle Anatomy 0.000 title claims abstract description 21
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 title abstract description 32
- 230000001965 increasing effect Effects 0.000 title abstract description 6
- 235000019136 lipoic acid Nutrition 0.000 claims abstract description 31
- 229960002663 thioctic acid Drugs 0.000 claims abstract description 30
- 150000001413 amino acids Chemical class 0.000 claims abstract description 29
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 8
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 1
- 229940093740 amino acid and derivative Drugs 0.000 claims 1
- 150000002308 glutamine derivatives Chemical class 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 17
- 239000000203 mixture Substances 0.000 abstract description 9
- 235000005911 diet Nutrition 0.000 abstract description 8
- 230000037213 diet Effects 0.000 abstract description 8
- 239000000126 substance Substances 0.000 abstract description 8
- 230000002708 enhancing effect Effects 0.000 abstract description 7
- 230000001502 supplementing effect Effects 0.000 abstract description 7
- 230000003278 mimic effect Effects 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 description 26
- 229940024606 amino acid Drugs 0.000 description 26
- 239000013589 supplement Substances 0.000 description 21
- 108010046377 Whey Proteins Proteins 0.000 description 19
- 102000007544 Whey Proteins Human genes 0.000 description 16
- 235000021119 whey protein Nutrition 0.000 description 15
- 239000007788 liquid Substances 0.000 description 9
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 6
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- -1 alkaline earth metal salts Chemical class 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 239000004475 Arginine Substances 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 239000005862 Whey Substances 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000008121 dextrose Substances 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 229960004308 acetylcysteine Drugs 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 229940046374 chromium picolinate Drugs 0.000 description 3
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
- 229910000160 potassium phosphate Inorganic materials 0.000 description 3
- 235000011009 potassium phosphates Nutrition 0.000 description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 235000019158 vitamin B6 Nutrition 0.000 description 3
- 239000011726 vitamin B6 Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940011671 vitamin b6 Drugs 0.000 description 3
- AGBQKNBQESQNJD-ZETCQYMHSA-N (S)-lipoic acid Chemical compound OC(=O)CCCC[C@H]1CCSS1 AGBQKNBQESQNJD-ZETCQYMHSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229940080839 methionine 500 mg Drugs 0.000 description 2
- 210000000663 muscle cell Anatomy 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- WRRSFOZOETZUPG-FFHNEAJVSA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;hydrate Chemical compound O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC WRRSFOZOETZUPG-FFHNEAJVSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 101000609762 Gallus gallus Ovalbumin Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960002648 alanylglutamine Drugs 0.000 description 1
- 108010044940 alanylglutamine Proteins 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M isovalerate Chemical compound CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229940073801 methionine 250 mg Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Food supplement compositions and their methods of use in increasing lean mass and/or muscle size and/or strength in individuals, particularly, athletes is described. The food supplements described comprise .alpha. lipoic acid or a derivative thereof, and an amino acid. Other food supplements described comprise a substance which can enhance and/or mimic activity of a lipoic acid, and a source of amino acid. The food supplement compositions described are suitable for supplementing the diet of an athlete and particularly for enhancing an athlete's muscle size and/or strength.
Description
a LIPOIC ACID BASED FOOD SUPPLEMENT FOR INCREASING LEAN
MUSCLE MASS AND STRENGTH
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of the U.S. provisional application Serial No.
60/178,957, filed February l, 2000, the content of which is incorporated herein by reference.
FIELD OF INVENTION
The present invention is directed to food supplements which comprise a lipoic acid or a derivative thereof, and a source of amino acids or derivatives thereof-, and to methods for supplementing the diet of an athlete and methods for enhancing an athlete's muscle size and/or strength, which methods employ these food supplements.
BACKGROUND OF INVENTION
Food supplements based on natural products and approaches for enhancing an athlete's muscle size and/or strength have become popular exigencies in various sports and body building regimes. However, as athletes continually strive for improved performance, there is a continuing need for new more effective technologies to aid in increasing lean muscle mass, muscle size and/or strength.
OBJECTS AND SUMMARY OF THE INVENTION
a lipoic acid (also known as alpha-lipoic acid, thioctic acid or 6,8-dithio octanoic acid and also referred to as lipoic acid) is a nutrient that the human body makes in minute quantities and may be obtained from yeast and liver. Studies have shown a lipoic acid can significantly increase the body's utilization of blood sugar in type 11 diabetes and that a lipoic acid may increase the metabolic clearance rate of glucose by 50% in type 11 diabetics. In Europe, a lipoic acid has been used as a substitute for insulin in the treatment of type ll diabetes.
The present invention relates to supplementing the diet of an athlete with a lipoic acid or a derivative thereof in combination with a source of amino acids or derivatives thereof, may provide surprising enhancement of an athlete's muscle size and/or strength when administered to an athlete's diet. Accordingly, in one broad aspect the present invention provides new food supplements to increase the delivery and uptake of amino acids in the body. Preferably the invention provides food supplements particularly adapted for supplementing the diet of an athlete, preferably the food supplements of the present invention enhance an athlete's muscle size and/or strength.
According to one embodiment of the present invention there is provided a food supplement comprising a lipoic acid or a derivative thereof, and, a source of amino acids or derivatives thereof. Preferably the source of amino acids is whey protein or a derwative thereof.
According to another embodiment of the present invention, there is provided a food supplement comprising a substance which mimics and/or enhances activity of a lipoic acid or a derivative thereof, the supplement also containing glutamine or a derivative thereof.
Preferably, where the substance enhances the activity of a lipoic acid or a derivative thereof, the supplement will contain both a lipoic acid or a derivative thereof and the enhancing substance.
According to another preferred embodiment, the supplements of the present invention comprise a a lipoic acid or a derivative thereof, and an amino acid or derivative thereof.
According to another preferred embodiment, the supplements of the present invention comprise a a lipoic acid or a derivative thereof, and glutamine or a derivative thereof.
In another broad aspect, the present invention provides methods of supplementing
MUSCLE MASS AND STRENGTH
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of the U.S. provisional application Serial No.
60/178,957, filed February l, 2000, the content of which is incorporated herein by reference.
FIELD OF INVENTION
The present invention is directed to food supplements which comprise a lipoic acid or a derivative thereof, and a source of amino acids or derivatives thereof-, and to methods for supplementing the diet of an athlete and methods for enhancing an athlete's muscle size and/or strength, which methods employ these food supplements.
BACKGROUND OF INVENTION
Food supplements based on natural products and approaches for enhancing an athlete's muscle size and/or strength have become popular exigencies in various sports and body building regimes. However, as athletes continually strive for improved performance, there is a continuing need for new more effective technologies to aid in increasing lean muscle mass, muscle size and/or strength.
OBJECTS AND SUMMARY OF THE INVENTION
a lipoic acid (also known as alpha-lipoic acid, thioctic acid or 6,8-dithio octanoic acid and also referred to as lipoic acid) is a nutrient that the human body makes in minute quantities and may be obtained from yeast and liver. Studies have shown a lipoic acid can significantly increase the body's utilization of blood sugar in type 11 diabetes and that a lipoic acid may increase the metabolic clearance rate of glucose by 50% in type 11 diabetics. In Europe, a lipoic acid has been used as a substitute for insulin in the treatment of type ll diabetes.
The present invention relates to supplementing the diet of an athlete with a lipoic acid or a derivative thereof in combination with a source of amino acids or derivatives thereof, may provide surprising enhancement of an athlete's muscle size and/or strength when administered to an athlete's diet. Accordingly, in one broad aspect the present invention provides new food supplements to increase the delivery and uptake of amino acids in the body. Preferably the invention provides food supplements particularly adapted for supplementing the diet of an athlete, preferably the food supplements of the present invention enhance an athlete's muscle size and/or strength.
According to one embodiment of the present invention there is provided a food supplement comprising a lipoic acid or a derivative thereof, and, a source of amino acids or derivatives thereof. Preferably the source of amino acids is whey protein or a derwative thereof.
According to another embodiment of the present invention, there is provided a food supplement comprising a substance which mimics and/or enhances activity of a lipoic acid or a derivative thereof, the supplement also containing glutamine or a derivative thereof.
Preferably, where the substance enhances the activity of a lipoic acid or a derivative thereof, the supplement will contain both a lipoic acid or a derivative thereof and the enhancing substance.
According to another preferred embodiment, the supplements of the present invention comprise a a lipoic acid or a derivative thereof, and an amino acid or derivative thereof.
According to another preferred embodiment, the supplements of the present invention comprise a a lipoic acid or a derivative thereof, and glutamine or a derivative thereof.
In another broad aspect, the present invention provides methods of supplementing
2 bodybuilding in an athlete comprising administering to the athlete an effective amount of a food supplement according to the present invention to achieve an increase in muscle size and/or strength.
Other features and advantages of the present invention will become apparent from the following detailed description. It should be understood, however, that the detailed description and the specific examples while indicating preferred embodiments of the invention are given by way of illustration only, since various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art from this detailed description.
DETAILED DESCRIPTION OF THE INVENTION
The food supplements and methods of the present invention may provide further and significant increase in muscle size and/or strength enhancement or improvement in individuals as compared with supplements and methods employing only proteins and/or amino acids or a lipoic acid alone. While it is expected that the supplements and methods of the present invention will be of importance to bodybuilders and other athletes, the supplements and methods of the invention are not limited to those groups.
Rather, any individual may use the supplements and methods of the invention. Indeed, the supplements and methods may have applications to all animals. As used herein, the term "animals"
includes all members of the animal kingdom, preferably humans. As used throughout the present specification a reference to an increase in muscle size is also understood to mean an increase in lean muscle mass.
The food supplements described herein comprise the compounds specifically identified and suitable derivatives thereof, for example a salt or ester.
Suitable salts include, but are not limited to, alkali and alkaline earth metal salts, for example sodium, potassium or calcium salts, while suitable esters include, but are not limited to, alkyl esters, for example, methyl, ethyl or propyl esters, or lactone esters.
Other features and advantages of the present invention will become apparent from the following detailed description. It should be understood, however, that the detailed description and the specific examples while indicating preferred embodiments of the invention are given by way of illustration only, since various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art from this detailed description.
DETAILED DESCRIPTION OF THE INVENTION
The food supplements and methods of the present invention may provide further and significant increase in muscle size and/or strength enhancement or improvement in individuals as compared with supplements and methods employing only proteins and/or amino acids or a lipoic acid alone. While it is expected that the supplements and methods of the present invention will be of importance to bodybuilders and other athletes, the supplements and methods of the invention are not limited to those groups.
Rather, any individual may use the supplements and methods of the invention. Indeed, the supplements and methods may have applications to all animals. As used herein, the term "animals"
includes all members of the animal kingdom, preferably humans. As used throughout the present specification a reference to an increase in muscle size is also understood to mean an increase in lean muscle mass.
The food supplements described herein comprise the compounds specifically identified and suitable derivatives thereof, for example a salt or ester.
Suitable salts include, but are not limited to, alkali and alkaline earth metal salts, for example sodium, potassium or calcium salts, while suitable esters include, but are not limited to, alkyl esters, for example, methyl, ethyl or propyl esters, or lactone esters.
3 As used herein "source of amino acid" means any peptide, polypeptides, protein or any composition of individual amino acids or individual amino acid. As will be readily appreciated by those skilled in the art, other sources of protein include milk protein, casein, any of the albumins including chicken egg albumin, and soy, may also be used as a source of amino acids.
Throughout the present specification, whey protein and a derivative thereof are identified as the preferred source of amino acids or protein. Commercially available whey protein derivatives include WPI 97, Whey Peptides, WPC 80, and lON EXCHANGE
whey protein, although any form of whey protein isolates (WPI), whey peptides, whey protein concentrate (WPC), or whey protein isolated by ion exchange may be used.
Additionally, hydrolyzed whey protein may be used.
Supplements Although the present invention is not to be limited by any theoretical explanation, it is believed that insulin is a primary factor that stimulates the uptake of glucose and amino acids into muscle cells and that the a lipoic acid both mimics and enhances the actions of insulin in glucose and amino acid transport into muscle cells. Insulin has been clearly shown to increase amino acid uptake into skeletal muscle, inhibit protein degradation, and stimulate protein synthesis: the net effect is an increase in protein efficiency and utilization. There it is theorized that a lipoic acid which mimics and enhances insulin sensitivity can decrease protein degradation and increase amino acid uptake, protein synthesis, nitrogen retention, muscle size and/or strength.
Accordingly, in its broad aspect the present invention provides a food supplement comprising a lipoic acid or a derivative thereof in combination with a source of amino acids.
According to one embodiment the source provides varied amino acids, preferably such source of amino acids is whey protein selected from the group consisting of WPI, Whey peptides, WPC, ion exchange whey protein, although as indicated above, other protein sources may be used.
Throughout the present specification, whey protein and a derivative thereof are identified as the preferred source of amino acids or protein. Commercially available whey protein derivatives include WPI 97, Whey Peptides, WPC 80, and lON EXCHANGE
whey protein, although any form of whey protein isolates (WPI), whey peptides, whey protein concentrate (WPC), or whey protein isolated by ion exchange may be used.
Additionally, hydrolyzed whey protein may be used.
Supplements Although the present invention is not to be limited by any theoretical explanation, it is believed that insulin is a primary factor that stimulates the uptake of glucose and amino acids into muscle cells and that the a lipoic acid both mimics and enhances the actions of insulin in glucose and amino acid transport into muscle cells. Insulin has been clearly shown to increase amino acid uptake into skeletal muscle, inhibit protein degradation, and stimulate protein synthesis: the net effect is an increase in protein efficiency and utilization. There it is theorized that a lipoic acid which mimics and enhances insulin sensitivity can decrease protein degradation and increase amino acid uptake, protein synthesis, nitrogen retention, muscle size and/or strength.
Accordingly, in its broad aspect the present invention provides a food supplement comprising a lipoic acid or a derivative thereof in combination with a source of amino acids.
According to one embodiment the source provides varied amino acids, preferably such source of amino acids is whey protein selected from the group consisting of WPI, Whey peptides, WPC, ion exchange whey protein, although as indicated above, other protein sources may be used.
4 According to another embodiment of the present invention, there is provided a food supplement comprising a substance which mimics and/or enhances the activity of a lipoic acid or a derivative thereof, the supplement also containing a source of amino acids.
According to a preferred embodiment, a source of amino acids is preferably selected from the group consisting of WPI, whey peptides, WPC, hydrolyzed whey protein, ion exchange whey protein, or lactoferrin, although as indicated above, any other protein source may be used.
According to another preferred embodiment, the supplements of the present invention comprise a a lipoic acid or a derivative thereof, and an amino acid or derivative thereof. Any amino acid type may be used in this embodiment, however only the single form of amino acid or a derivative thereof is used. For example, the combination may include ieucine, isoleucine, valine, arginine, or alanine or peptides like alanyl-glutamine, glutamine-glycine.
According to another embodiment of the present invention, there is provided a food supplement comprising a substance which mimics and/or enhances activity of a lipoic acid or a derivative thereof, the supplement also containing glutamine or a derivative thereof.
According to another embodiment, a food supplement of the present invention comprises a lipoic acid or a derivative thereof and glutamine or a derivative thereof.
As will be readily appreciated by those skilled in the art, the supplement is not limited to only one form of a lipoic acid or a derivative thereof and one source of amino acids. Indeed the present invention provides for combinations of substances and sources of amino acids, in differing amounts.
The food supplement compositions of the present invention may be provided in a variety of formats, for example, in liquid form, powder form, protein bar form or encapsulated in liposomes. Powders are preferable and are prepared to be suitable for
According to a preferred embodiment, a source of amino acids is preferably selected from the group consisting of WPI, whey peptides, WPC, hydrolyzed whey protein, ion exchange whey protein, or lactoferrin, although as indicated above, any other protein source may be used.
According to another preferred embodiment, the supplements of the present invention comprise a a lipoic acid or a derivative thereof, and an amino acid or derivative thereof. Any amino acid type may be used in this embodiment, however only the single form of amino acid or a derivative thereof is used. For example, the combination may include ieucine, isoleucine, valine, arginine, or alanine or peptides like alanyl-glutamine, glutamine-glycine.
According to another embodiment of the present invention, there is provided a food supplement comprising a substance which mimics and/or enhances activity of a lipoic acid or a derivative thereof, the supplement also containing glutamine or a derivative thereof.
According to another embodiment, a food supplement of the present invention comprises a lipoic acid or a derivative thereof and glutamine or a derivative thereof.
As will be readily appreciated by those skilled in the art, the supplement is not limited to only one form of a lipoic acid or a derivative thereof and one source of amino acids. Indeed the present invention provides for combinations of substances and sources of amino acids, in differing amounts.
The food supplement compositions of the present invention may be provided in a variety of formats, for example, in liquid form, powder form, protein bar form or encapsulated in liposomes. Powders are preferable and are prepared to be suitable for
5 mixing with water or other liquids. The food supplement compositions in powder or granular form may be provided in accordance with customary processing techniques, for example as spray dried powders, or the like.
The food supplement compositions can also contain ascorbic acid (vitamin C), for example in amounts equal to or exceeding the recommended minimum daily requirements.
Another component for possible use in the food supplements of the present invention comprises beta-hydroxy, beta-methyl butyrate (IiNB), in amounts known in the art. As will be appreciated by those skilled in the art, supplements may include one or more of a large number of other component which include, as non-limiting examples, carbohydrates, dextrose, vitamins, minerals, herbs, prohormones, ribose and lecithin.
The food supplement compositions may further comprise natural and/or artificial flavoring components, dyes or other coloring additives, preservatives and other I ~ conventional food supplement additives known in the art.
Methods of Use of Supplements The food supplements according to the present invention may be employed in methods for supplementing the diet of an athlete, and/or for enhancing an athlete's muscle size and/or strength. The food supplement compositions of the present invention are particularly advantageous for creating an increased anabolic environment for obtaining extra growth in lean muscle mass and/or strength. Accordingly, the present invention provides methods of supplementing bodybuilding in an athlete comprising administering to the athlete an effective amount of a food supplement according to the present invention.
Administration of an effective amount of the supplements and substances of the present invention is defined as an amount effective, at dosages and for periods of time necessary to achieve the desired result. The effective amount of the supplements of the invention may vary according to factors such as the age, sex, and weight of the athlete.
Dosage regime may be adjusted to provide the optimum response: Several divided doses
The food supplement compositions can also contain ascorbic acid (vitamin C), for example in amounts equal to or exceeding the recommended minimum daily requirements.
Another component for possible use in the food supplements of the present invention comprises beta-hydroxy, beta-methyl butyrate (IiNB), in amounts known in the art. As will be appreciated by those skilled in the art, supplements may include one or more of a large number of other component which include, as non-limiting examples, carbohydrates, dextrose, vitamins, minerals, herbs, prohormones, ribose and lecithin.
The food supplement compositions may further comprise natural and/or artificial flavoring components, dyes or other coloring additives, preservatives and other I ~ conventional food supplement additives known in the art.
Methods of Use of Supplements The food supplements according to the present invention may be employed in methods for supplementing the diet of an athlete, and/or for enhancing an athlete's muscle size and/or strength. The food supplement compositions of the present invention are particularly advantageous for creating an increased anabolic environment for obtaining extra growth in lean muscle mass and/or strength. Accordingly, the present invention provides methods of supplementing bodybuilding in an athlete comprising administering to the athlete an effective amount of a food supplement according to the present invention.
Administration of an effective amount of the supplements and substances of the present invention is defined as an amount effective, at dosages and for periods of time necessary to achieve the desired result. The effective amount of the supplements of the invention may vary according to factors such as the age, sex, and weight of the athlete.
Dosage regime may be adjusted to provide the optimum response: Several divided doses
6 may be administered daily or the dose may be proportionally reduced as indicated by the exigencies of an individual athlete's situation.
As will be readily appreciated a food supplement in accordance with the present invention may be administered in a single serving or in multiple servings spaced throughout the day. In a preferred embodiment, a food supplement in accordance with the present invention may be administered once in the morning, once immediately or shortly after training and once in the evening on a daily basis. As will be understood by those skilled in the art, servings need not be Limited to daily administration, and may be on an every second or third day or other convenient effective basis. As well the administration on a given day may be in a single serving or in multiple servings spaced throughout the day depending upon the exigencies of the situation.
In order to maximize the effects of a food supplement according to the present invention, in enhancing muscle size and/or strength, it is preferred that the food supplement is administered to the diet of the athlete immediately following an exercise period. On non-workout days, the food supplement may be administered anytime during the day, although administering a first amount of a food supplement upon awakening or otherwise during the morning hours is preferred.
The embodiments set forth in the present application are provided only to illustrate various aspects of the invention and additional embodiments and advantages of the food supplements and methods of the present invention will be apparent to those skilled in the an.
EXAMPLES
The present invention will be further explained in the following examples.
However, the present invention should not be construed as limited as to scope and nature of the present invention. One of the ordinary skill in the an will understand how to vary the exemplified preparations to obtain the desired results.
As will be readily appreciated a food supplement in accordance with the present invention may be administered in a single serving or in multiple servings spaced throughout the day. In a preferred embodiment, a food supplement in accordance with the present invention may be administered once in the morning, once immediately or shortly after training and once in the evening on a daily basis. As will be understood by those skilled in the art, servings need not be Limited to daily administration, and may be on an every second or third day or other convenient effective basis. As well the administration on a given day may be in a single serving or in multiple servings spaced throughout the day depending upon the exigencies of the situation.
In order to maximize the effects of a food supplement according to the present invention, in enhancing muscle size and/or strength, it is preferred that the food supplement is administered to the diet of the athlete immediately following an exercise period. On non-workout days, the food supplement may be administered anytime during the day, although administering a first amount of a food supplement upon awakening or otherwise during the morning hours is preferred.
The embodiments set forth in the present application are provided only to illustrate various aspects of the invention and additional embodiments and advantages of the food supplements and methods of the present invention will be apparent to those skilled in the an.
EXAMPLES
The present invention will be further explained in the following examples.
However, the present invention should not be construed as limited as to scope and nature of the present invention. One of the ordinary skill in the an will understand how to vary the exemplified preparations to obtain the desired results.
7 In this example , an sthlete consumes two servings of the food supplement as described herein daily,a serving of the food supplement immediately following his/her workout, and an additional serving 4 hours post workout. Each serving of the food supplement is about 100 grams and contains the following:
Component Amount a Lipoic acid 200 mg Glutamine 20 g Dextrose 60 g Whey Protein 30 g Arginine 1 g Leucine 1 g Phenylalanine 1 g Methionine 500 mg Glycosidal Saponins 200 mg N-Acetyl cysteine 100 mg Vitamin B6 10.5 mg Magnesium 200 mg Vitamin E 400 IU
Potassium Phosphate 100 mg Chromium Picolinate 200 mc~
Each approximate 100 gram serving is mixed with about 15 ounces of cold water to provide a liquid drink. An additional 8 ounces of water may be consumed after the food supplement liquid drink is consumed.
EXAN>pLE 2 In this example, an athlete consumes two servings of the food supplement as described herein daily, a serving of the food supplement immediately following his/her
Component Amount a Lipoic acid 200 mg Glutamine 20 g Dextrose 60 g Whey Protein 30 g Arginine 1 g Leucine 1 g Phenylalanine 1 g Methionine 500 mg Glycosidal Saponins 200 mg N-Acetyl cysteine 100 mg Vitamin B6 10.5 mg Magnesium 200 mg Vitamin E 400 IU
Potassium Phosphate 100 mg Chromium Picolinate 200 mc~
Each approximate 100 gram serving is mixed with about 15 ounces of cold water to provide a liquid drink. An additional 8 ounces of water may be consumed after the food supplement liquid drink is consumed.
EXAN>pLE 2 In this example, an athlete consumes two servings of the food supplement as described herein daily, a serving of the food supplement immediately following his/her
8 workout, and an additional serving 4 hours post workout. Each serving of the food supplement is about 120 grams and contains the following:
Composition Amount a Lipoic acid 200 mg Glutamine 10 g Dextrose 75 g Whey Protein 30 g Arginine 1 g Leucine 1 g Phenylalanine 1 g Methionine 500 mg Glycosidal Saponins 200 mg N-Acetyl cysteine 100 mg Vitamin B6 10.5 mg Magnesium 200 mg Vitamin E 400 IU
Potassium Phosphate 100 mg Chromium Picolinate 200 mc~
Each approximate 100 gram serving is mixed with about 15 ounces of cold water to provide a liquid drink. An additional 8 ounces of water may be consumed after the food supplement liquid drink is consumed.
EXAIug'LE 3 The muscle size and/or strength enhancing regime of Examplel is modified so that the athlete consumes four servings of the food supplement daily, with each serving being approximately 55 g of the supplement and comprising:
Component Amount
Composition Amount a Lipoic acid 200 mg Glutamine 10 g Dextrose 75 g Whey Protein 30 g Arginine 1 g Leucine 1 g Phenylalanine 1 g Methionine 500 mg Glycosidal Saponins 200 mg N-Acetyl cysteine 100 mg Vitamin B6 10.5 mg Magnesium 200 mg Vitamin E 400 IU
Potassium Phosphate 100 mg Chromium Picolinate 200 mc~
Each approximate 100 gram serving is mixed with about 15 ounces of cold water to provide a liquid drink. An additional 8 ounces of water may be consumed after the food supplement liquid drink is consumed.
EXAIug'LE 3 The muscle size and/or strength enhancing regime of Examplel is modified so that the athlete consumes four servings of the food supplement daily, with each serving being approximately 55 g of the supplement and comprising:
Component Amount
9 a Lipoic acid 100 mg Glutamine 10 g Dextrose 30 g Whey Protein 15 g Arginine 0.5 g Leucine 0.5 g Phenylalanine 0.5 g Methionine 250 mg Glycosidal Saponins 100 mg N-Acetyl cysteine 50 mg Vitamin B6 5.25 mg Magnesium 100 mg Vitamin E 200 IU
Potassium Phosphate 50 mg Chromium Picolinate 100 mcQ
Each supplement serving is mixed with 8 ounces of cold water to provide a liquid drink. An additional 8 ounces may be consumed after the food supplement liquid drink is consumed.
The dosage regime described in Example I is completed, on workout days. The serving is consumed immediately after exercise and then again 4 hours later.
On non-exercising days the athlete consumes the food supplement as described in Example 2. The serving is consumed upon waking, prior to bed, and at two other time points during the day.
Alternatively the supplement is combined with other liquid drinks or foods as desired. The regime is continued for a minimum of 8 weeks to enhance increases in muscle size and/or strength.
The servings set forth in these examples are designed for a 2500 calorie diet.
Daily values can be increased or decreased depending on the needs of the individual athlete.
The examples and embodiments set forth in the present applications are provided only to illustrate various aspects of the invention and additional embodiments and advantages of the food supplements and method of the present invention will be apparent to those skilled in the art.
Potassium Phosphate 50 mg Chromium Picolinate 100 mcQ
Each supplement serving is mixed with 8 ounces of cold water to provide a liquid drink. An additional 8 ounces may be consumed after the food supplement liquid drink is consumed.
The dosage regime described in Example I is completed, on workout days. The serving is consumed immediately after exercise and then again 4 hours later.
On non-exercising days the athlete consumes the food supplement as described in Example 2. The serving is consumed upon waking, prior to bed, and at two other time points during the day.
Alternatively the supplement is combined with other liquid drinks or foods as desired. The regime is continued for a minimum of 8 weeks to enhance increases in muscle size and/or strength.
The servings set forth in these examples are designed for a 2500 calorie diet.
Daily values can be increased or decreased depending on the needs of the individual athlete.
The examples and embodiments set forth in the present applications are provided only to illustrate various aspects of the invention and additional embodiments and advantages of the food supplements and method of the present invention will be apparent to those skilled in the art.
Claims (2)
1. A food supplement which comprises a lipoic acid or a derivative thereof, and at least one ingredient selected from the group consisting of amino acids and derivatives thereof and sources of amino acids, in amounts effective to increase lean muscle mass and strength; wherein the amount of glutamine or glutamine derivative is about
2 mg per gram of food supplement.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60/178,957 | 2000-02-01 | ||
CA002399500A CA2399500A1 (en) | 2000-02-01 | 2001-02-01 | Alpha lipoic acid based food supplement for increasing lean muscle mass and strength |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002399500A Division CA2399500A1 (en) | 2000-02-01 | 2001-02-01 | Alpha lipoic acid based food supplement for increasing lean muscle mass and strength |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2468211A1 true CA2468211A1 (en) | 2001-08-09 |
Family
ID=32660892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002468211A Abandoned CA2468211A1 (en) | 2000-02-01 | 2001-02-01 | .alpha. lipoic acid based food supplement for increasing lean muscle mass and strength |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2468211A1 (en) |
-
2001
- 2001-02-01 CA CA002468211A patent/CA2468211A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040208942A1 (en) | Alpha lipoic acid based food supplement for increasing lean muscle mass and strength | |
US6620425B1 (en) | Food supplements and methods comprising lipoic acid and creatine | |
US7795204B2 (en) | Food supplement for increasing lean mass and strength | |
US6784209B1 (en) | Food supplement for increasing lean mass and strength | |
US7288570B2 (en) | Stimulation of in vivo production of proteins | |
EP1093337B1 (en) | Food supplements comprising lipoic acid and creatine and methods for their use | |
CA2246014C (en) | Food supplements and methods comprising lipoic acid and creatine | |
CA2468211A1 (en) | .alpha. lipoic acid based food supplement for increasing lean muscle mass and strength | |
JPH10174564A (en) | Combined healthy food derived from livestock product | |
KR19980065988A (en) | Combination health food derived from animal products |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |